Real-life experience on COVID-19 and seasonal influenza vaccines co-administration in the vaccination hub of the University Hospital of Palermo, Italy

References

• Italian Ministry of Health. Recommendations for prevention and control of influenza for the 2022/2023 season in Italy; 2022 [accessed 2023 Oct 20]. https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2022&codLeg=87997&parte=1%20&serie=null.
   Google Scholar
• World Health Organization. Review of global influenza circulation, late 2019 to 2020, and the impact of the COVID-19 pandemic on influenza circulation; 2021 [accessed 2023 Oct 20]. https://www.who.int/publications/i/item/who-wer-9625-241-264.
   Google Scholar
• InfluNet. National epidemiological report of respiratory diseases; 2022 [accessed 2022 Sept 22]. https://www.salute.gov.it/portale/temi/documenti/epidemiologica/Influnet_2021_16.pdf.
   Google Scholar
• European Centre for Disease Prevention and Control. Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA; 2022 [accessed 2023 Oct 20]. https://www.ecdc.europa.eu/en/publications-data/intensified-circulation-respiratory-syncytial-virus-rsv-and-associated-hospital.
   Google Scholar
• Kissling E, Maurel M, Emborg HD. Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023. Euro Surveill. 2023 May;28(21):2300116. doi:10.2807/1560-7917.ES.2023.28.21.2300116.
   PubMedGoogle Scholar
• Watson O, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022 Sept;22(9):1293–8. doi:10.1016/S1473-3099(22)00320-6.
   PubMed Web of Science ®Google Scholar
• Domnich A, Cambiaggi M, Vasco A, Maraniello L, Ansaldi F, Baldo V, Bonanni P, Calabrò GE, Costantino C, de Waure C, et al. Attitudes and beliefs on influenza vaccination during the COVID-19 pandemic: results from a representative Italian survey. Vaccines (Basel). 2020 Nov 30;8(4):711. doi:10.3390/vaccines8040711.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Abrysvo respiratory syncytial virus vaccine (bivalent, recombinant) authorization; 2023 Sept. [accessed 2023 Oct 20]. https://www.ema.europa.eu/en/medicines/human/EPAR/abrysvo#:~:text=Why%20is%20Abrysvo%20authorised%20in,Abrysvo%20were%20mild%20or%20moderate.
   Google Scholar
• European Medicines Agency. Arexvy (recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E) authorization; 2023 June. [accessed 2023 Oct 20]. https://www.ema.europa.eu/en/medicines/human/EPAR/arexvy.
   Google Scholar
• Italian Ministry of Health. COVID-19 vaccines report administered updated to 14th January 2023; 2023 [accessed 2023 Oct 20]. https://www.governo.it/it/cscovid19/report-vaccini/.
   Google Scholar
• Italian Ministry of Health. Influenza vaccination coverage in Italy; 2022 [accessed 2023 Oct 20]. https://www.salute.gov.it/portale/influenza/dettaglioContenutiInfluenza.jsp?lingua=italiano&id=679&area=influenza&menu=vuoto.
   Google Scholar
• Italian Ministry of Health. Recommendations for prevention of influenza for the 2021/2022 season; 2022 [accessed 2023 Oct 20]. https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&codLeg=79647&parte=1%20&serie=null.
   Google Scholar
• Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, Emmett SR, Garstang J, Gbadamoshi L, Hallis B, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdox1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021 Dec 18;398(10318):2277–2287. doi:10.1016/S0140-6736(21)02329-1.
   PubMed Web of Science ®Google Scholar
• Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022 Feb;10(2):167–179. doi:10.1016/S2213-2600(21)00409-4.
   PubMed Web of Science ®Google Scholar
• Domnich A, Orsi A, Trombetta CS, Guarona G, Panatto D, Icardi G. COVID-19 and seasonal influenza vaccination: cross-protection, co-administration, combination vaccines, and hesitancy. Pharmaceuticals (Basel). 2022 Mar 8;15(3):322. doi:10.3390/ph15030322.
   PubMedGoogle Scholar
• Izikson R, Brune D, Bolduc JS, Bourron P, Fournier M, Moore TM, Pandey A, Perez L, Sater N, Shrestha A, et al. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study 4. Lancet Respir Med. 2022 Apr;10(4):392–402. doi:10.1016/S2213-2600(21)00557-9.
   PubMed Web of Science ®Google Scholar
• Centre for Disease Prevention and Control. Use of COVID-19 vaccines in the United States; 2021 [accessed 2023 Oct 20]. https://www.cdc.gov/vaccines/COVID-19/clinical-considerations/COVID-19-vaccines-us.html#Coadministration.
   Google Scholar
• World Health Organization. Coadministration of seasonal inactivated influenza and COVID-19 vaccines; 2022 [accessed 2023 Oct 20]. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-coadministration-influenza-vaccines.
   Google Scholar
• HAS Sante France. Covid-19 et grippe : la HAS précise les conditions d’une co-administration des vaccins; 2022 [accessed 2023 Oct 20]. https://www.has-sante.fr/jcms/p_3288855/fr/COVID-19-et-grippe-la-has-pre.
   Google Scholar
• STIKO-Empfehlung zur Koadministration. Epidemiologisches Bulletin [accessed 2023 Oct 20]. https://edoc.rki.de/bitstream/handle/176904/8809/EB-39-2021-STIKO-Empfehlung-Koadministration-Online-vorab.pdf?sequence=1&isAllowed=y.
   Google Scholar
• Ministerio De Sanidad. Vacunas y Programa de Vacunación. [accessed 2023 Oct 20]. https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/.
   Google Scholar
• Finnish Institute for Health and welfare (THL). New recommendations for coronavirus vaccinations – pregnant women may take a coronavirus vaccine if they wish; 2022 [accessed 2023 Oct 20]. https://thl.fi/en/web/thlfi-en/-/new-recommendations-for-coronavirus-vaccinations-pregnant-women-may-take-a-coronavirus-vaccine-if-they-wish.
   Google Scholar
• UK Government. COVID-19 green book chapter 14a; 2022 [accessed 2023 Oct 20]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1102459/Greenbook-chapter-14a-4September22.pdf.
   Google Scholar
• Russian Federation Ministry of Health. COVID-19 and influenza vaccine co-administration; 2022 [accessed 2023 Oct 20]. https://minzdrav.gov.ru/news/2021/10/22/17665-minzdrav-rossii-razreshil-odnovremennuyu-vaktsinatsiyu-ot-kovida-i-grippa.
   Google Scholar
• Istat. Demographical data of Italian population [accessed 2024 Jan 31]. https://demo.istat.it/.
   Google Scholar
• Capodici A, Montalti M, Soldà G, Salussolia A, La Fauci G, Di Valerio Z, Scognamiglio F, Fantini MP, Odone A, Costantino C, et al. Influenza vaccination landscape in Italy: a comprehensive study through the OBVIOUS project lens. Hum Vaccin Immunother. 2023 Aug;19(2):2252250. doi:10.1080/21645515.2023.2252250.
   PubMed Web of Science ®Google Scholar
• Castro I, Van Tricht M, Bonaccorso N, Sciortino M, Garcia Burgos J, Costantino C, Gonzalez-Quevedo R. Stakeholders’ understanding of European medicine agency’s COVID-19 vaccine information materials in EU and regional contexts. Vaccines (Basel). 2023 Oct 19;11(10):1616. doi:10.3390/vaccines11101616.
   PubMed Web of Science ®Google Scholar
• Bendau A, Plag J, Petzold MB, Ströhle A. COVID-19 vaccine hesitancy and related fears and anxiety. Int Immunopharmacol. 2021 Aug;97:107724. doi:10.1016/j.intimp.2021.107724.
   PubMed Web of Science ®Google Scholar
• Italian National Medices Agency. Fourteenth report on the surveillance of COVID-19 vaccines [accessed 2024 Jan 31]. https://www.aifa.gov.it/en/-/quattordicesimo-rapporto-aifa-sulla-sorveglianza-dei-vaccini-anti-covid-19.
   Google Scholar
• Di Giuseppe G, Pelullo CP, Della Polla G, Montemurro MP, Napolitano F, Pavia P, Angelillo IF. Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy. Expert Rev Vaccines. 2021 July;20(7):881–889. doi:10.1080/14760584.2021.1922081.
   PubMed Web of Science ®Google Scholar
• Di Giuseppe G, Pelullo CP, Paolantonio A, Della Polla G, Pavia M. Healthcare workers’ willingness to receive influenza vaccination in the context of the COVID-19 pandemic: a survey in southern Italy. NATO Adv Sci Inst Se. 2021;9(7):766. doi:10.3390/vaccines9070766.
   Google Scholar